TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Exercise capacity (watts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to work after 12 and 24 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: HIF‐1α expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Micro-vessel density (MVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endometrial apoptosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NEI VFQ-25 composite score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Troponin I or CK-MB values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vertical CDR measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HRT disc area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Glaucoma probability score (GPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximal ventricular rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: hyperemic MBF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage area stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: leg pain intensity difference from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AOFAS hindfoot scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First intermetatarsal angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: residual tumor presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: time-to-relapse/recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Relapses of chronic pouchitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Secretory endometrial transformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean plasma progesterone concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: FEV₁ (Forced Expiratory Volume in 1 second)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ankle sprain recurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FADI scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient satisfaction with near and distant vision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Spectacle dependence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Likelihood of providing specimens for genetic study
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of sensor value comparisons
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients randomized
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: G1 birthweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent days of cannabis use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent days of alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental and denture hygiene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from oral diseases or symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Improvement (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Client preferences discussion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Case activity tailoring to client preferences
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Recurrences of P. vivax malaria
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients reaching predefined symptom threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of saxagliptin and its metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of saxagliptin
Endpoint domain: Adverse events/effects
Primary endpoint: Volume of lung receiving 20 Gy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean lung dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Arousals per hour of sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-ventilator asynchronies per hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: collection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of heel punctures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: re-collection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Alzheimer's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Child abuse investigations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Possible maternal anxiety or depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: proportion of patients with hospital-acquired postoperative positive urine cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: adaptation of nicotine replacement therapy effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative cumulative opioid consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause mortality at 60 days
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of AGI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Intra-stent tissue area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal stent diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak creatine kinase (CK)-MB fraction levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of MDD within 2 years
Endpoint domain: Mortality/survival
Primary endpoint: 2-h insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Treatment rate for genital infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-voiding residual urine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: voiding volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: detrusor pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean surgically induced astigmatism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deviation from neutral alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virological failure (VF) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: personality characteristics measured by TCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response (>= 50% reduction in YMRS total score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: difference ratio of solar keratoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cognitive scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tendon repair simulation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinol increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fmax improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: favourable patient outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time to onset of sensory block at T10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median duration of sensory block at T10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time to complete regression of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose of protamine
Endpoint domain: Adverse events/effects
Primary endpoint: Chance of adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerance of Iobitridol
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic quality of Iobitridol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: parent/caregiver satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: gastrointestinal quality of life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pain perception
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Total effective rate in patients after SIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent of easy infant temperament type
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cost of phacoemulsification surgery
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Cost of SICS surgery
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: REM sleep suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fat mass decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: prevalence of no-reflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement of cognitive functions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Blood cell gene expression profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plasma antioxidant biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: infant morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Integrated postprandial gallbladder volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pain intensity reduction at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of flow expiratory volume in one second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean change in glycated hemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rates of overall confirmed hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: psychometric validity of the Brief-APQ
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Grade 3 or 4 drug-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Deaths from pulmonary toxicity
Endpoint domain: Mortality/survival
Primary endpoint: Clearance of M6G
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the miotic effect-versus-time curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anterior capsule movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Low Birth Weight (LBW)
Endpoint domain: Mortality/survival
Primary endpoint: Small for Gestational Age (SGA)
Endpoint domain: Mortality/survival
Primary endpoint: average power output during the TT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of sexual function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum depth of local anaesthetic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean bias between temperature measurement methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial seizure threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HAM-D score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sevoflurane EC50 for successful intravenous cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lumbar region motion parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal wound architecture and integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in nonvellus hair count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Investigator assessment of hair growth/scalp coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient assessment of treatment benefit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative acetaminophen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: End-of-life (EOL) preparation
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Slow-wave sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in specific relevant outcomes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensitivity and specificity for diagnosis of acute myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: success rate of external cephalic version
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal intensive care unit admission (NICU) rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: IBS SSS at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to the next bipolar episode
Endpoint domain: Mortality/survival
Primary endpoint: Social and occupational functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in plasma HIV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean daily amount of fluid in front drains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median days until removal of drains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean fracture load values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance variables of strength, endurance, and power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: critical cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: Pain scores using the Hamburg Pain Adjective List
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Staining properties of the smear
Endpoint domain: Adverse events/effects
Primary endpoint: Cellular content of the smear
Endpoint domain: Adverse events/effects
Primary endpoint: SEI continuation rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in daily steps walked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional QOL score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: non‐stimulated salivary flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage fall in FEV(1) (DeltaFEV(1))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of treatment failure
Endpoint domain: Mortality/survival
Primary endpoint: Time to recovery from lower chest wall indrawing and sternal retraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to resolution for all respiratory symptoms of severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Acceptability of Mii-vitaliSe
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Wii use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: change of bloating/pain intensity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: change of satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Effective regurgitant orifice area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Strain improvement in anterolateral PM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Strain improvement in posteromedial PM adjacent wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: visual acuity decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of VMA/VMT resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of FTMH closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in BCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of urethral stricture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-reactive protein (hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tHcy reduction by B‐vitamin treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum liver enzymes improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Projected survival at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: antibiotic use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fasting LDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Knowledge and attitude towards clinical research
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitudes towards participation in scientific research
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Confidence in clinical research
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: RQ variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: IBS‐SSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medial femoral condyle T1ρ and T2 changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KFM (Knee Flexion Moment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KFA (Knee Flexion Angle)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in quality of life (KPS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: bond strength to sound dentin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nano leakage in adhesive systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SLEDAI‐2K scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of renal disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Presence of vasculitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory deficit reversal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uterine scar separation rate
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma serotonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Composite endpoint of prolonged ICU stay, mortality, or both
Endpoint domain: Mortality/survival
Primary endpoint: subjective state on the VAS scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: percent of subjects using a toothbrush
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent of subjects brushing with fluoride toothpaste
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: net cavitated carious increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: advertisement content recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-identity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing